XML 21 R11.htm IDEA: XBRL DOCUMENT v3.8.0.1
Shareholders' Equity (Tables)
9 Months Ended
Sep. 30, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Summary of Share-based Compensation Expense
Total share-based compensation expense related to all share-based awards for the three and nine months ended September 30, 2017 and 2016 was comprised of the following (in thousands):
 
Three Months Ended 
 September 30,
 
Nine Months Ended
September 30,
 
2017
 
2016
 
2017
 
2016
Research and development:
 
 
 
 
 
 
 
   Stock options
$
3,068

 
$
1,678

 
$
8,083

 
$
4,154

   Restricted stock

 

 

 
30

   Warrants
24

 
10

 
58

 
25

Research and development share-based compensation expense
3,092

 
1,688

 
8,141

 
4,209

General and administrative:
 
 
 
 
 
 
 
   Stock options
2,203

 
1,666

 
6,151

 
4,934

   Restricted stock

 
516

 
409

 
1,645

   Warrants
187

 
56

 
475

 
183

General and administrative share-based compensation expense
2,390

 
2,238

 
7,035

 
6,762

Total share-based compensation expense included in expenses
$
5,482

 
$
3,926

 
$
15,176

 
$
10,971

Stock Options, Valuation Assumptions
The Company estimated the fair value of each stock option grant on the grant date using the Black-Scholes model with the following weighted-average assumptions:
 
Nine Months Ended
September 30,
 
2017
 
2016
Expected volatility
143
%
 
141
%
Expected life
6.19 years

 
5.74 years

Risk-free interest rate
2.0
%
 
1.3
%
Dividend yield

 

Summary of Stock Option Activity
The Company’s 2013 Equity Plan stock option activity for the nine months ended September 30, 2017 was comprised of the following:
 
Outstanding Stock Options and 2013 Equity Plan
 
Shares
Underlying
Stock Options
 
Weighted-
Average
Exercise Price
per Share
Outstanding at December 31, 2016
2,627,462

 
$
21.07

Granted
1,879,925

 
$
22.97

Exercised
(152,342
)
 
$
15.48

Forfeited
(93,608
)
 
$
21.77

Outstanding at September 30, 2017
4,261,437

 
$
22.09

Summary of Restricted Stock Activity
The Company’s restricted stock award activity for the nine months ended September 30, 2017 was comprised of the following:
 
Number of
Shares
 
Weighted-
Average Grant
Date Fair
Market Value
Unvested at December 31, 2016
542,680

 
$
13.22

Vested
(542,680
)
 
$
13.22

Unvested at September 30, 2017

 
$